+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inovio Pharmaceuticals Inc - logo

Inovio Pharmaceuticals is a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. The company has developed antigen-targeting immunotherapy and vaccine product candidates for HPV-caused precancers and cancers, breast, lung, pancreatic, and prostate cancer, hepatitis, HIV, influenza, Ebola, and other diseases. Inovio was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Antimicrobial Therapeutics Market 2024-2028 - Product Thumbnail Image

Antimicrobial Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 175 Pages
  • Global
From
From
COVID-19 Vaccines - Global Strategic Business Report - Product Thumbnail Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 762 Pages
  • Global
From
Digital Vaccines - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 274 Pages
  • Global
From
Subunit Vaccines - Global Strategic Business Report - Product Thumbnail Image

Subunit Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 279 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • October 2025
  • 573 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 468 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 336 Pages
  • Global
From
Combination Vaccines - Global Strategic Business Report - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 373 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 171 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 279 Pages
  • Global
From
Malaria Vaccines - Global Strategic Business Report - Product Thumbnail Image

Malaria Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 371 Pages
  • Global
From
Loading Indicator